Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qalian is a French-based leader in the animal health sector, specializing in the design, manufacture, and marketing of veterinary products and nutritional solutions. The company's portfolio encompasses a wide range of therapeutic categories, including anti-infectives, antiparasitics, and specialty nutritional supplements for livestock such as poultry, swine, and cattle. Following its acquisition by ADM in 2019 as part of the Neovia group, Qalian has integrated into ADM’s Animal Nutrition business unit. The company is recognized for its expertise in biosecurity and its commitment to the 'One Health' initiative, promoting sustainable animal production. Qalian maintains a significant international presence, exporting its products to over 50 countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qalian.